Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Grey matter degeneration during multiple sclerosis is linked to activation of neuronal necroptosis by oxidized phosphatidylcholines.

Research square·2026
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Gaining biological insights through supervised data visualization.

Nature computational science·2026
Same author

Cerebellar magnetization transfer ratio and its relationship to clinical outcomes in radiologically isolated syndrome and multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Related Experiment Video

Updated: May 11, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K

Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international,

Edward De Brouwer1, Thijs Becker2,3, Lorin Werthen-Brabants4

  • 1ESAT-STADIUS, KU Leuven, Belgium.

PLOS Digital Health
|July 25, 2024
PubMed
Summary

Machine learning models can predict multiple sclerosis disability progression using routine data. Historical progression, not treatment or relapses, is the strongest predictor, aiding clinical decisions.

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.0K

Related Experiment Videos

Last Updated: May 11, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.0K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Biostatistics

Background:

  • Disability progression is a critical indicator in multiple sclerosis (MS) evolution.
  • Current prediction models lack clinical trust and a standardized benchmark.
  • There is a need for reliable tools to forecast MS disability progression.

Purpose of the Study:

  • To develop and validate machine learning models for predicting disability progression in people with MS (PwMS).
  • To establish a benchmark for assessing MS disability progression prediction models.
  • To evaluate the utility of routinely collected variables in predicting MS progression.

Main Methods:

  • Utilized data from 15,240 PwMS across 146 centers in 40 countries (MSBase consortium).
  • Applied state-of-the-art machine learning models following TRIPOD guidelines for prediction over two years.
  • Validated models using external datasets five times, assessing discrimination (ROC-AUC, AUC-PR) and calibration (Brier score, ECE).

Main Results:

  • Machine learning models demonstrated good performance with ROC-AUC of 0.71 ± 0.01 and AUC-PR of 0.26 ± 0.02.
  • Model calibration was adequate, with a Brier score of 0.1 ± 0.01 and ECE of 0.07 ± 0.04.
  • Past disability progression was a more significant predictor than treatment history or relapses.

Conclusions:

  • Routinely collected variables are sufficient for accurate MS disability progression prediction.
  • Machine learning models show promise for clinical application, informing decisions about future MS progression.
  • The developed models and code serve as a benchmark for future MS progression prediction research.